Search company, investor...
23andMe company logo

23andMe

23andme.com

Founded Year

2006

Stage

Corporate Minority - P2P | IPO

Total Raised

$877.69M

Revenue

$0000 

About 23andMe

23andMe is a personal genetics company dedicated to helping individuals understand genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service enables individuals to gain deeper insights into ancestry and inherited traits. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research.

Headquarters Location

349 Oyster Point Blvd

South San Francisco, California, 94080,

United States

650-938-6300

Compete with 23andMe?

Ensure that your company and products are accurately represented on our platform.

23andMe's Products & Differentiators

    Ancestry +Traits Service

    Traces your genetic heritage and creates your genetic family tree. This product also gives your likelihood of expressing 30+ genetic traits like you fear of heights or if you are more likely to prefer chocolate or vanilla ice cream. You can find details on the product at https://www.23andme.com/

Expert Collections containing 23andMe

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

23andMe is included in 12 Expert Collections, including Conference Exhibitors.

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

T

Tech IPO Pipeline

568 items

D

Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

M

Medical Devices

12,555 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health Monitoring & Diagnostics

2,736 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

23andMe Patents

23andMe has filed 1 patent.

The 3 most popular patent topics include:

  • Genetics
  • Molecular biology
  • DNA
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/14/2022

11/22/2022

DNA, Molecular biology, Genetics, Biotechnology, Database management systems

Grant

Application Date

1/14/2022

Grant Date

11/22/2022

Title

Related Topics

DNA, Molecular biology, Genetics, Biotechnology, Database management systems

Status

Grant

Latest 23andMe News

23ANDME (ME) SHAREHOLDER ALERT - Andrews & Springer LLC Is Investigating 23andMe For Potential Securities Violations and Breaches of Fiduciary Duty

Nov 14, 2022

Wilmington, Delaware, UNITED STATES WILMINGTON, Del., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential securities violations and breach of fiduciary duty claims against 23andMe Holding Co. (“23andMe” or the “Company”)(NASDAQGS: ME). If you currently own shares of 23andMe and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/23andme-class-action-investigation/ or contact Craig J. Springer, Esq. at  cspringer@andrewsspringer.com , or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc , Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates. Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. These traits are the hallmarks of  our innovative approach to each case our Firm decides to prosecute. For more information please visit our website at www.andrewsspringer.com . This notice may constitute Attorney Advertising. Contact:

23andMe Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

23andMe Rank

23andMe Frequently Asked Questions (FAQ)

  • When was 23andMe founded?

    23andMe was founded in 2006.

  • Where is 23andMe's headquarters?

    23andMe's headquarters is located at 349 Oyster Point Blvd, South San Francisco.

  • What is 23andMe's latest funding round?

    23andMe's latest funding round is Corporate Minority - P2P.

  • How much did 23andMe raise?

    23andMe raised a total of $877.69M.

  • Who are the investors of 23andMe?

    Investors of 23andMe include GSK, Casdin Capital, Fidelity Investments, Altimeter Capital, Foresite Capital and 31 more.

  • Who are 23andMe's competitors?

    Competitors of 23andMe include Viome, Human Longevity, FOXO Technologies, LifeNome, LetsGetChecked, One Medical, Prenetics, WeGene, CloudSeq, Helix and 25 more.

  • What products does 23andMe offer?

    23andMe's products include Ancestry +Traits Service and 3 more.

Compare 23andMe to Competitors

Color Logo
Color

Color democratizes access to genetic information. The Color Test is physician-ordered and comes with complimentary board-certified genetic counseling for clients and healthcare providers. The 30-gene Color Test analyzes genes closely associated with some of the most common hereditary cancers: breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers.

Helix Logo
Helix

Helix connects people with the most fundamental aspect of what makes them unique: their own DNA. The company empowers consumers to discover and explore their own genomes through insights provided by its ecosystem of content partners.

P
Prosper eDNA

Prosper eDNA increases accuracy and planning for insurance companies working in life, long-term care and annuities by making accurate lifespan predictions, and enabling personalized epigenetic (not genetic) monitoring.

Human Longevity Logo
Human Longevity

Human Longevity is building a comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging-related disease and human biological decline. The company is developing and applying large-scale computing and machine learning to make discoveries from this data to generate personalized health insights. Its goal is to extend healthy human life by impacting human health and transforming the practice of medicine. Human Longevity was founded in 2013 and is based in San Diego, California.

Ancestry Logo
Ancestry

Ancestry offers a website offering family history information, historical records and other genealogical information. Ancestry.com offers several localized Web sites designed to empower people to discover, preserve and share family history. Ancestry has more than 2.2 million paying subscribers across its core Ancestry websites and approximately 1.5 million DNA samples in the AncestryDNA database.

LetsGetChecked Logo
LetsGetChecked

LetsGetChecked offers at-home tests for a variety of conditions. The company builds and delivers at-home testing kits, including hormone tests, fertility tests, HPV tests and wellness tests for cholesterol or diabetes. Its services includes manufacturing, logistics, lab analysis, clinician support, and prescription fulfillment. The company was founded in 2015 and is based in Dublin, Ireland.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.